Diffuse parenchymal lung diseases (DPLDs) in children or childhood interstitial lung disease (CHILD), as they are widely known, encompass a heterogeneous group of rare diffuse lung diseases characterized by abnormal imaging findings, restrictive ventilation, and impaired gas exchange, associated with substantial morbidity and mortality. A novel classification scheme has been proposed by the CHILD Research Cooperative, which is largely based on the presumed etiology and morphology of the diseases. The latter are categorized according to prevalence in infancy. A multidisciplinary approach is mandatory for the diagnosis and management, with imagingdespecially computed tomography (CT)dplaying a pivotal role in suggesting or even corroborating a diagnosis, refining the differential diagnosis, identifying possible biopsy sites, monitoring disease activity, and assessing response to therapy. In this pictorial essay, we attempted a short and comprehensive review of CHILD syndrome while highlighting the role of imaging through illustrative cases of the main entities.
Terminology and Classification
Childhood Interstitial Lung Disease (CHILD) CHILD constitutes a heterogeneous group of rare diffuse lung diseases, characterized by abnormal imaging findings, restrictive ventilation, and impaired gas exchange associated with substantial morbidity and mortality [1, 2] . This definition, which has not been studied prospectively, is sensitive for detecting the presence of a CHILD, but its specificity is yet to be determined. Furthermore, CHILD is a misnomer, considering the fact that the entities under its umbrella are not confined in the lung interstitium. However, the term CHILD has been globally accepted by the scientific community [3] .
Diffuse Parenchymal Lung Diseases
DPLDs are entities originating from the lung interstitium concerning the alveolar epithelium, vessel endothelium, and tissues between these structures in the periphery of the lung, the peribronchiolar and peribronchial tissues more centrally, as well as the lung parenchyma per se. Airways may be involved secondarily during progression of the disease [1, 4] .
Excluded from the above definition are diseases presented as localized gross structural abnormalities of the lungs affecting the parenchymal tissue, disorders primarily affecting the airways or the pleura, lung infections, and neoplasms.
To the clinicians' aid in identifying children with a potential CHILD syndrome, 4 criteria have been established (respiratory symptoms [cough, dyspnea, or exercise intolerance], respiratory signs [resting tachypnea, adventitious sounds, retractions, digital clubbing, failure to thrive, or respiratory failure], hypoxemia, diffuse pulmonary parenchymal abnormality on chest radiograph or CT]), at least 3 of which should be met in order to conclude to a diagnosis [4] . The aforementioned criteria should be applied once more common entities have been eliminated from the differential diagnosis, such as asthma, pulmonary infection, cystic fibrosis, immunodeficiency, congenital heart disease, bronchopulmonary dysplasia, primary ciliary dyskinesia presenting with newborn respiratory distress, and recurrent aspiration [1] .
A novel classification scheme has been proposed by the CHILD Research Cooperative, which is largely based on the presumed etiology and morphology of the diseases. Entities are categorized according to prevalence in infancy or not. In children less than 2 years of age, the differential diagnosis includes diffuse developmental disorders, growth abnormalities, specific conditions of unknown etiology, and genetic surfactant dysfunction disorders. In older children, the classification includes disorders of the normal host, disorders of the immuno-compromised host, disorders related to systemic disease, as well as disorders mimicking ILD [1, 5, 6] .
It should be underlined that distinct pathologies and clinical disorders among different etiologic categories tend to overlap [7] . The classification is illustrated in Table 1 [1, 5] .
After completing the initial evaluation, including thorough history and clinical examination, according to findings, HRCT is prescribed, which detects the presence of DPLDs, refines the initial differential diagnosisdsometimes concluding to a definite diagnosisdor even providing guidance for further diagnostic work-up, like pulmonary function tests, bronchoscopy with bronchoalveolar lavage (BAL), or even more invasive procedures, like open lung biopsy or video-assisted thoracoscopic surgery. Last but not least, genetic testing should not be omitted, although its limitations should be taken into consideration (including belated results), since it allows the diagnosis of only known disorders, and so far only a minority of DPLDs have a genetic cause [8, 9] . Congestive changes related to cardiac dysfunction CHILD ¼ childhood interstitial lung disease; CPI ¼ chronic pneumonitis of infancy; DIP ¼ desquamative interstitial pneumonia; ILD ¼ interstitial lung disease; NSIP ¼ nonspecific interstitial pneumonia; PAP ¼ pulmonary alveolar proteinosis.
The Role of Imaging
Chest radiograph, albeit being the starting point, is highly non-specific with a limited sensitivity. CT is the gold standard in the work-up of interstitial lung disease in pediatric patients, since it provides information about the extent and distribution of parenchymal disorders (pattern recognition), contributing in estimating the severity of the disease, the response to treatment and the prognosis, as well as indicating a site for biopsy [2, 3, 10] . Occasionally, abnormalities affecting other systems (eg, cardiovascular) may be diagnosed. In some cases, CT findings are pathognomonic, determining the diagnosis and obviating excessive interventional procedures. CT may be complemented by other modalities according to findings, like ultrasound, magnetic resonance imaging, scintigraphy, etc.
Technical Details
The challenge of performing a CT scan on a child involves acquiring the necessary image quality for the diagnosis, whilst ensuring the least risk for the patient. Conventional high-resolution computed tomography (HRCT) is a valuable technique to gain information on the pattern and anatomical distribution of lung diseases. Iterative reconstruction techniques are applied, substituting conventional filtered back-projection, accomplishing reduction of image noise, permitting lower radiation dose and sharper reconstruction algorithms (better depiction of ground-glass opacities, small nodules, etc) [7] .
The designated HRCT protocol used in our institution involves images acquired at end-inspiration, sampling w1 mm slice of lung parenchyma, with a 10 mm interslice gap (5e7 mm in infants, 15e20 mm for follow-up scans) [2, 11] . The collected data are reconstructed on a high spatial resolution (bony) algorithm for optimal lung parenchymal display. End expiration images are then obtained (3e4 sample slices) [7, 12] . In order to maintain the radiation dose as low as possible, examinations are performed using 80 KV voltage and 40e50 mAs settings, while in the follow-up studies the interval between sections is increased from 10 mm to 15e20 mm. A non-contrast noncontiguous sequence is reserved for investigating or following up studies of patients with established diffuse airways or interstitial lung disease, whilst by applying continuous volumetric CT scan, we can obtain HRCT images, in addition to extracting information about surrounding tissues (mediastinum, vessels, heart, thoracic cage, etc) [2, 11, 12] .
For children younger than 4 years old, pressure-controlled ventilation may be applied, which is in fact the technique of choice for obtaining HRCT images, keeping in mind that atelectasis can develop within minutes. However, it should be complemented with scanning in prone position [2] . The purpose of this technique is to achieve a respiratory pause, during which inspiration and expiration are simulated by applying positive airway pressure (or not). In order to do so, the child is sedated and via a face mask, hyperventilation with positive pressure is exerted resulting in hypocarbia, and the induction of the desirable respiratory pause. It should be noted that the technique is demanding depending on stuff expertise and the child's respiratory rate [2, 7] . Alternatively, ultra-fast free-breathing CT is performeddwith or without sedation customized individuallydwith no strict control of lung volume. In the free-breathing CT, the patient should be Figure 5 . A 22-month-old infant with neuroendocrine cell hyperplasia of infancy, confirmed with lung biopsydcomputed tomography scan shows ground glass opacities in the right middle lobe, the lingula, and the right lower lobe in paramediastinal location (arrowheads). On the expiration scan mosaic attenuation airtrapping is noted. Figure 6 . Term neonate without infection, continuous respiratory distress 2 days after delivery, with increased oxygen demands, not responding to surfactant administration. Extensive patchy increased density (asterisk) sparing the subpleural areas are illustrated throughout both lungs, due to genetic surfactant disorder (SP-C deficiency). scanned in lateral decubitus position on one side, followed by the contralateral side. The more dependent lung butting against the scanner's table acts as if in expiration, while the overlying lung is in inspiration [11, 13, 14] .
Disorders More Prevalent in Infancy (<2 Years of Age)
Growth Abnormalities
Bronchopulmonary dysplasia
Traditionally, bronchopulmonary dysplasia (BPD) is attributed to positive pressure mechanical ventilation and oxygen toxicity. On chest radiographs, the most prominent findings of the ''old'' BPD include reticular opacities, cystic lesions, disarrayed lung aeration, and hyperinflation ( Figure 1 ) [2] . On CT, similarly, reticular opacities, air-trapping, and multifocal areas of reduced density of the lung parenchyma are demonstrated, as well as marked bronchial wall thickening, all mainly attributed to fibrotic and inflammatory changes, as well as airway injury (Figure 2 ) [15] .
However, advances in perinatal medicine, including administration of antenatal glucocorticoids, surfactant replacement therapy, and refined ventilatory strategies, have decreased lung injury from barotrauma and oxygen toxicity and lowered the threshold of viability in premature neonates. Hence, a ''new'' kind of BPD has recently emerged, attributed to a lowered threshold of viability to around 23 weeks of gestational age early in the development of the alveolar ducts and alveoli. New BPD nowadays concerns extremely premature neonates, with arrested or delayed alveolar and pulmonary vascular development. The imaging findings on CT scan are subtle, including hyperlucent areas, linear opacities, as well as triangular subpleural opacities (Figures 3 and 4) [2, 7] .
Conditions of Undefined Etiology

Neuroendocrine cell hyperplasia of infancy (persistent tachypnea of infancy)
Patients with neuroendocrine cell hyperplasia of infancy, aged under 2 years old, usually present with tachypnea, hypoxemia, and failure to thrive. The course is prolonged and does not respond to steroids. The infant's pulmonary function tests are conclusive for severe air-trapping. Histopathologically, an increased number of pulmonary neuroendocrine cells in the epithelium of the peripheral Figure 9 . Langerhans cell histiocytosisdcomputed tomography scan shows (A) multiple nodules, thin-walled cysts, and thick-walled cysts of irregular shape practically involving the entire lung with relative sparing of the lung bases and characteristic sparing of the medial tips of the middle lobe and lingula. With disease progression (B), the child was admitted with a spontaneous pneumothorax while the cysts were thin-walled and larger. airways is observed, which rapidly decreases after the neonatal period.
On chest radiographs, hyperinflation may be noted, while on CT scans, findings are highly specific, which include geographic ground glass opacities with paramediastinal distribution in the right, middle lobe, and the lingula, affecting at least 4 lobes. On the expiration scan, mosaic attenuation air-trapping is detected. When the clinical context matches the radiological findings, usually no further invasive investigation is required ( Figure 5 ) [2, 8, 9, 16] .
Surfactant Dysfunction Mutations and Related Disorders
Mapping mutations associated with the structure and metabolism of proteins involved in surfactant function has provided valuable insights, considering the complexity and overlap of these disorders, which concern a wide range of age groups [9] . The so-far-unraveled entities include SP-B deficiency, SP-C deficiency, ABCA3 deficiency, etc ( Figure 6 ) [16] . Figure 11 . Idiopathic pulmonary hemosiderosisdcomputed tomography scan shows extensive diffuse ground-glass opacities, with limited areas of interstitial septal thickening forming polygons (arrowheads). Tiny cysts are also present (arrow). Figure 12 . Bronchiolitis obliteransdcomputed tomography scan shows bronchial wall thickening, bronchiectasis (arrowhead), geographic parenchymal hyperlucency, with reduced vessel size and number, corresponding to expiratory air-trapping.
Pulmonary Alveolar Proteinosis
Three clinically distinct forms of pulmonary alveolar proteinosis (PAP) have been described: autoimmune, secondary, and congenital. Genetic PAP (errors affecting surfactant metabolism) is seen more commonly in term neonates presenting with unexplained severe respiratory distress syndrome and not responding to surfactant administration. As for the secondary and autoimmune form met in older children, they more closely mirror adult disease [7] .
On chest radiographs, hazy granular shadows are described. CT findings in PAPdirrespective of typed include diffuse ground-glass shadows, consolidations, septal thickening, and crazy paving. However, during the course of congenital PAP, ground-glass shadows decrease and thinwalled cysts emerge, which increase in number and size with age. Septal thickening, consolidations, and pectus excavatum may also be seen (Figures 7 and 8) [2, 7] . Genetic tests, BAL, and lung biopsy may contribute to the diagnosis.
Disorders Not Specific to Infancy
Disorders Related to Systemic Diseases
Langerhans cell histiocytosis
Langerhans cell histiocytosis is a proliferation of CD1a þ histiocytes (Langerhanscells) infiltrating organs locally or diffusely. Pulmonary involvement is rare. Nevertheless, a CT scan should be performed in all newly diagnosed patients with Langerhans cell histiocytosis, since 50% of cases with lung involvement are asymptomatic.
On chest radiograph diffuse nodulars, reticulonodular interstitial shadows are observed. On CT scans, nodules which may cavitate, and form cysts of irregular shape are illustrated. Spontaneous pneumothorax is a potential complication. An enlarged thymus may also be seen with intrathymic calcification-cavitation being characteristic of the disease, rendering lung biopsy unnecessary ( Figure 9) [7, 10, 13] .
Storage diseases: Gaucher and Niemann-Pick
Gaucher and Niemann-Pick disease is actually a group of distinct autosomal recessive lysosomal storage diseases. Niemann-Pick is attributed to a defect in sphingomyelinase production, while Gaucher disease is caused by a deficiency of b-glucosidase [11] .
Findings are non-specific for the diagnosis of lung involvement. On chest radiographs, reticulonodular shadows are noted. On CT scans, diffuse ground-glass shadows may be present, interstitial septal thickening, consolidations, bronchial wall thickening-bronchiectasis, and enlarged lymph nodes (hilar-mediastinal) ( Figure 10 ). Thymic enlargement may also be seen [7, 11] . Lung involvement can be confirmed with BAL (in already known cases), or even with lung biopsy in undiagnosed cases.
Pulmonary hemorrhage
Pulmonary hemorrhage encompasses a wide differential diagnoses, including pulmonary capillaritis, primary or Figure 13 . Nine-year-old patient with myeloblastoma receiving chemotherapy with lung toxicity attributed to the therapeutic agent. Computed tomography scan shows diffuse patchy ground glass opacities and consolidations along the bronchovascular bundle, accompanied by small random nodules (arrowhead). associated with another vasculitis, (Wegener granulomatosis), microscopic polyangiitis, Goodpasture disease, or systemic lupus erythematosus. When the above are excluded, pulmonary venous hypertension, idiopathic pulmonary hemosiderosis, Heiner syndrome, and coagulation syndromes should be suspected. Precise diagnosis is of high importance due to the different and often aggressive therapeutic scheme on the aforementioned entities [7, 13] . A clinical clue for suspecting pulmonary hemorrhage is a decrease of hematocrit, while hemoptysis is unusual. BAL may be required to confirm the presence of pulmonary alveolar hemorrhage. Although fluffy centrilobular opacities are indicative of disruption of the alveolar interstitial capillary network, definitive diagnosis often requires lung biopsy. On chest radiographs, the findings are non-specific, including bilateral airspace and/or interstitial opacities. On CT scans, acute hemorrhage presents with patchy ground-glass opacities and consolidation, while septal thickening, crazy paving appearance, and tiny cysts are representative of a more chronic procedure, which may coexist ( Figure 11) [2, 7, 14] .
Disorders of the normal host
This subcategory involves children with an intact immune system and includes post-inflammatory responses, reactions to environmental agents, eosinophilic pneumonia, and aspiration.
Bronchiolitis obliterans
The most commonly encountered entity is bronchiolitis obliterans as a result of a respiratory viral infection. Findings on chest radiographs are subtle and non-specific, with hyperinflation usually being the only finding. On CT scans, findings may include bronchial wall thickening, bronchiectasis, geographic parenchymal hyperlucency, and expiratory air-trapping ( Figure 12 ) [10] .
Disorders of the immunocompromised host
Immunosuppression in pediatric populations encompasses a broad spectrum of opportunistic infections, disorders related to therapeutic interventions, rejection syndromes, or even diffuse alveolar damage of unknown etiology (Figure 13 ).
Disorders masquerading as ILD
A numbers of disorders are mimickers of interstitial lung disease, including arterial hypertensive/congestive vasculopathy, lymphatic disorders, and congestive changes related to cardiac dysfunction, and should be taken into consideration when diffuse lung disease is suspected ( Figure 14) [7] .
Conclusion
CHILD represents a wide spectrum of diseases characterized by their diversity and rarity, as well as their high Figure 14 . A child with aortic valve stenosis and concomitant pathological findings in computed tomography, including diffuse reticular interstitial pattern with increased lung attenuation and tiny cysts. morbidity and mortality. Our knowledge of the aforementioned entities remains, however, limited. Constant research is much needed, surfacing insights, like the relatively recent emergence of novel genetic entities, creating a necessity for familiarity with the classification, clinical presentation, histopathology, genetics and characteristic imaging, in order to promptly diagnose and manage effectively these frail patients.
